The invention relates to the expression of the cDNA clone for sub-units a1(hsGCa1) and b1 (hsGCb1) of human soluble guanylylcyclase and the subsequentpurification of the active enzyme and use thereof, the medical application ofthe expression of this clone by gene transfer, in addition to antibodiesagainst peptides derived from said sequence and the use thereof.